The Drugs Controller General of India (DCGI) earlier this month granted permission for the emergency use of 2-Deoxy-D-Glucose drug as an adjunct therapy in moderate-to-severe Covid patients. This FYI explainer looks at what the drug does, what the clinical trials have said and how effective will it be in the fight against Covid.